DDX41 and myasthenia gravis: Myasthenia gravis (MG) is an autoimmune disorder characterized by muscle weakness and fatigue that primarily affects the neuromuscular junction through the production of autoantibodies against acetylcholine receptor antibodies (AChR-Abs) and muscle-specific kinase antibodies (MuSK-Abs) [1].